| Name | hCAIX/XII-IN-8 |
|---|---|
| Synonyms | Benzenesulfonamide, 4-[2-[1-(2,4-dichlorophenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazinyl] |
| Description | hCAIX/XII-IN-8 (compound 3g) is a potent human (carbonic anhydrase) CA IX and XII inhibitor, with Ki values of 8.5 and 6.7 nM, respectively. hCAIX/XII-IN-8 shows particularly strong inhibitory activity against the tumor-associated membrane-bound isoforms, hCA IX and XII, while maintaining a high selectivity ratio over cytosolic off-target isoforms hCA I and II[1]. |
|---|---|
| Related Catalog | |
| Target |
hCA XII:6.7 nM (Ki) hCA IX:8.5 nM (Ki) hCA II:72.0 nM (Ki) hCA I:5269 nM (Ki) |
| References |
| Molecular Formula | C16H13Cl2N5O3S |
|---|---|
| Molecular Weight | 426.28 |